Sort
25,944 grants matching “neurodegeneration”
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$955,065Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2009 · DA
24-hour Activity Cycles to Optimize Cognitive Resilience to Alzheimer's Disease in African Americans: The Jackson Heart Study
$955,061Kelley Pettee Gabriel · University Of Alabama At Birmingham · R01 · FY2021 · AG
A new model of accelerated immune aging in HIV-infected drug users
$955,000Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2019 · DA
A new model of accelerated immune aging in HIV-infected drug users
$955,000Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2014 · DA
A new model of accelerated immune aging in HIV-infected drug users
$955,000Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2018 · DA
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$954,827Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2008 · DA
GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD
$954,537James G. Moe · Oligomerix, Inc · R44 · FY2020 · AG
NEUROSCIENCE CORE CENTER
$954,269Francis W Flynn · University Of Wyoming · P30 · FY2013 · GM
Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs
$953,849Maria Maccecchini · Annovis Bio, Inc. · U01 · FY2019 · AG
Mechanisms of axon guidance during development
$953,257Edward Giniger · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Stroke Disordered Breathing and its Impact on Cognitive Decline in Aging, Alzheimer's Disease and Cerebral Amyloid Angiopathy
$953,252Jun Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG
Stress Granules and the Biology of TDP-43
$953,194Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2016 · ES
Role of Neurotrophins in the Development of the Mammalian Nervous System
$952,123Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS
$952,090Brigham And Women'S Hospital · P01 · FY2000 · AG
COCHLEAR SYNAPTOPATHY AND NEURODEGENERATION AFTER NOISE
$950,428Massachusetts Eye And Ear Infirmary · · FY2016 · Department of the Navy
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.
$948,518Srikant Rangaraju · Yale University · R01 · FY2025 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$948,369Kurt R. Brunden · University Of Pennsylvania · U01 · FY2019 · AG
Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders
$948,191Eric M Morrow · Brown University · R01 · FY2020 · NS
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
$948,191Eric M Morrow · Brown University · R01 · FY2022 · NS
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
$948,191Eric M Morrow · Brown University · R01 · FY2021 · NS
MOTOR NEURON DISEASE--A PROGRAM PROJECT
$946,766University Of Chicago · P01 · FY2000 · NS
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$946,116Kurt R. Brunden · University Of Pennsylvania · U01 · FY2020 · AG
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
$945,774Ed Lein · Allen Institute · U19 · FY2021 · AG
Calpain as a Therapeutic Target for TBI (P01)
$945,560James W Geddes · University Of Kentucky · P01 · FY2010 · NS
Calpain as a Therapeutic Target for TBI (P01)
$945,555James W Geddes · University Of Kentucky · P01 · FY2011 · NS